↓ Skip to main content

Cochrane Database of Systematic Reviews

Natalizumab for relapsing remitting multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, October 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
13 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
80 Dimensions

Readers on

mendeley
297 Mendeley
Title
Natalizumab for relapsing remitting multiple sclerosis
Published in
Cochrane database of systematic reviews, October 2011
DOI 10.1002/14651858.cd007621.pub2
Pubmed ID
Authors

Eugenio Pucci, Giorgio Giuliani, Alessandra Solari, Silvana Simi, Silvia Minozzi, Carlo Di Pietrantonj, Ian Galea

Abstract

Natalizumab (NTZ) (Tysabri(®)) is a monoclonal antibody that inhibits leukocyte migration across the blood-brain barrier, thus reducing inflammation in central nervous system, and has been approved worldwide for the treatment of relapsing-remitting multiple sclerosis (RRMS).

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 297 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
Brazil 2 <1%
Chile 1 <1%
Italy 1 <1%
Sri Lanka 1 <1%
United Kingdom 1 <1%
Unknown 289 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 53 18%
Student > Bachelor 32 11%
Student > Ph. D. Student 30 10%
Researcher 29 10%
Other 22 7%
Other 51 17%
Unknown 80 27%
Readers by discipline Count As %
Medicine and Dentistry 104 35%
Psychology 23 8%
Nursing and Health Professions 21 7%
Agricultural and Biological Sciences 10 3%
Social Sciences 9 3%
Other 36 12%
Unknown 94 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2020.
All research outputs
#898,047
of 21,537,483 outputs
Outputs from Cochrane database of systematic reviews
#2,028
of 12,070 outputs
Outputs of similar age
#3,989
of 119,238 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 57 outputs
Altmetric has tracked 21,537,483 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,070 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,238 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.